Completed OBSERVATIONAL NCT00184821

Ischemic Injury and Ischemic Preconditioning in Diabetes

Acute Local Ischemic Preconditioning in Patients With Type 1 Diabetes in Vivo

Sponsor: Dutch Diabetes Fund

Conditions Diabetes Mellitus, Insulin-Dependent Ischemia-Reperfusion Injury

Interventions Annexin A5 scintigraphy Diazoxide Forearm ischemic exercise Ischemic preconditioning adenosine glibenclamide

Updated 7 times since 2017 Last updated: Apr 4, 2007 Started: Jun 30, 2004 Completion: May 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Diabetes Mellitus, Insulin-Dependent and Ischemia-Reperfusion Injury and is currently completed. Dutch Diabetes Fund leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2022 — Jul 2024 [monthly]

Completed
Jan 2021 — Mar 2022 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dutch Diabetes Fund
Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands